Chong‐Jen Yu
National Taiwan University(TW)National Taiwan University Hospital(TW)National Hsinchu University of Education(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis
Most-Cited Works
- → Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer(2020)1,691 cited
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study(2017)1,138 cited
- → Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6(2015)970 cited
- → Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia(2020)815 cited
- → MicroRNA Signature Predicts Survival and Relapse in Lung Cancer(2008)